The negative outlook: Long-term follow up of ThyroSeq negative and low-risk nodules.

Raquel A PerryMegan F LeeRachel C JugRajesh C DashDaniel J RockeXiaoyin 'Sara' Jiang

Published in: Cancer cytopathology (2024)

ThyroSeq testing has good negative predictive value and can help risk stratify cytologically indeterminate nodules. Routine follow-up allows for safe monitoring of nodules for features suggestive of malignancy.

Keyphrases

fine needle aspiration
ultrasound guided